Has Donald Ansert received payments from drug or device companies?

Yes. Drug and device makers reported $18,067 in general payments to Donald Ansert across 581 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Donald Ansert did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Donald Ansert come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Donald Ansert

Foot & Ankle Surgery · New Albany, INNPI 1508838939

Payments from drug & device makers

$18,067in general payments, 2019–2025

Across 581 payments — averaging $31.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$3K
Stryker$2K
Amgen$1K
Paratek Pharmaceuticals, Inc.$1K
Organogenesis Inc.$1K
Alpha Orthopedic Systems$960
plus $8K from 48 others

What the payments were for

Travel & lodging$9986%
Food & beverage$14,60481%
Education$2,46514%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	11	$3,123
Stryker(2 entities)	28	$1,978
Amgen(2 entities)	65	$1,382
Paratek Pharmaceuticals, Inc.	71	$1,266
Organogenesis Inc.	58	$1,116
Alpha Orthopedic Systems	7	$960
Smith+Nephew	77	$872
Tactile Systems Technology Inc	28	$759
AbbVie(2 entities)	25	$534
Integra Lifesciences Corporation	4	$437
Johnson & Johnson	14	$425
Bone Support Inc.	7	$364
Inari Medical, Inc.	2	$357
Misonix Inc	15	$315
Convatec Inc.	4	$278
Medtronic(2 entities)	4	$275
Treace Medical Concepts, Inc.	4	$272
Kerecis Limited	3	$263
Sebela Pharmaceuticals Inc.	14	$259
Vertex	7	$243
Sanara Medtech Inc.	4	$221
Nevro Corp.	7	$215
Bioventus LLC	12	$198
Zyla Life Sciences, Inc.	20	$196
Blue Surgical LLC	3	$170
Kowa Pharmaceuticals America, Inc.	25	$167
Pfizer	11	$159
Medline Industries LP	1	$139
Ortho Dermatologics, A Division Of Bausch Health US, LLC	3	$137
Triad Life Sciences Inc.	1	$121
Melinta Therapeutics, LLC	6	$108
Royal Biologics, Inc.	4	$96
Mimedx Group, Inc.	2	$76
Reprise Biomedical, Inc.	5	$64
Encore Dermatology Inc.	3	$59
Boston Scientific	3	$58
Next Science LLC	2	$55
Acera Surgical, Inc.	1	$45
Abbott	2	$40
Surgenex LLC	1	$28
Nabriva Therapeutics, PLC	2	$27
Celularity Inc.	1	$24
Averitas Pharma Inc.	1	$21
Mckesson Patient Care Solutions Inc.	1	$20
Sandoz	1	$18
GSK	1	$17
Medartis Inc.	1	$15
La Jolla Pharmaceutical Company	1	$15
Alfasigma USA, Inc.	1	$15
Globus Medical	1	$14
Paragon 28, Inc.	1	$13
Aroa Biosurgery Incorporated	2	$13
Hikma Pharmaceuticals USA	1	$12
Orthofix Medical, Inc.	2	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTEGRA$1,271
Kerecis SurgiClose$585
INTEGRA DERMAL REGENERATION TEMPLATE$424
PRIMATRIX$424
FLOWTRIEVER CATHETER, S$357
CT THROMBECTOMY SYSTEM KIT$357
PROPHECY$332
VARIAX$301
CARTIVA$277
CERAMENTBONE VOID FILLER$266
PuraPly$238
EASYFUSE$233
INTELLIS ADAPTIVESTIM$213
Kerecis GraftGuide$146
CellerateRx$141
TMC NANOPLASTY SYSTEM$134
CERAMENT G$129
ORTHOLOC 2 LAPIFUSE$129
JOURNAVX$125
Senza$122

How this compares

$18,067 in reported general payments places this provider in the 85th percentile of 212 foot & ankle surgery providers in Indiana.

See all foot & ankle surgery providers in Indiana →

Medicare billing

Part B allowed, 2024

$1,390,650

Medicare patients

655

Services billed

10,741

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Terbinafine Hcl	173	$2,642
Ammonium Lactate	128	$2,423
Linezolid	19	$2,062
AmantadineAmantadine Hcl	11	$1,388
Mupirocin	171	$914
Meloxicam	73	$841
Ciclopirox	30	$810
Gabapentin	35	$786
Celecoxib	13	$543
Levofloxacin	28	$363
Ketoconazole	14	$360
Diclofenac Sodium	17	$258
Doxycycline Hyclate	36	$255
SsdSilver Sulfadiazine	19	$191
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	39	$190

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in New Albany

Theodore SpiresNew Albany$14K
Jonathan PrimeNew Albany$12K
Steven HerbstMuncie$1.6M
Douglas BlacklidgeKokomo$689K
Patrick DeheerIndianapolis$493K
Scott NevilleMooresville$353K
Travis MontgomeryWestfield$345K
Robert Clemency IiiSchererville$215K
William AdamsGreenfield$178K
Christopher WintersCarmel$158K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →